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Abstract
I n  r e c e n t  d e c a d e s  a n t e n a t a l  s c r e e n i n g  h a s  b e c o m e  o n e  o f  t h e  m o s t  r o u t i n e  p r o c e d u r e  o f
pregnancy-follow up and the subject of hot debate in bioethics circles. In this paper the rationale
behind doing antenatal screening and the actual and potential problems that it may cause will be
discussed. The paper will examine the issue from  the point of wiew of parents, health care
professionals and, most importantly, the child-to-be. It will show how unthoughtfully antenatal
screening is performed and how pregnancy is treated almost as a disease just since the emergence
of antenatal screening. Genetic screening and ethical problems caused by the procedure will also
be addressed and I will suggest that screening is more to do with the interests of others rather than
those of the child-to be.
Introduction
Antenatal testing (ANT) is widely used in modern obstet-
rics and gynaecology. I shall discuss the procedures in-
volved in ANT from different perspectives, beginning
with definitions of 'antenatal screening' and 'antenatal
diagnosis', the main objectives and indications for their
use. Secondly, I will discuss the risks and complications
of ANT, the concerns, doubts and moral controversies it
raises. Thirdly, since counselling is an integral part of
ANT, I shall try to determine what the ideal of counsel-
ling before and after ANT is meant to be. Finally, with
particular reference to some relevant concepts like 're-
sponsibility', 'suffering' and 'interest', I attempt to de-
scribe the whole issue more comprehensively.
Recent studies have indicated that the major paediatric
health problems are handicaps due to genetic disorder or
congenital malformation. When it was noticed that more
than a quarter of all deaths in the first year of life were
due to fetal abnormalities [1], scientists were alarmed
and parents sought a 'remedy' for the 'problem'. Al-
though antenatal diagnostic techniques were initially de-
scribed in the nineteenth century, it was not until the
middle of 20th century that the techniques were applied
to AND and management of various genetic disorders
and congenital malformations. And, at the present time,
antenatal screening and diagnostic techniques are al-
most the norm. It has been said that, probably around
90% of women in the UK have undergone one of these at
some time during pregnancy [2]. Although there is only
a slight difference between the two procedures, the au-
thorities do distinguish between antenatal screening
(ANS) and antenatal diagnosis (AND).
Aims of antenatal testing
ANS services are based on population screening to iden-
tify people with a genetic risk, or a risk of having a child
with a congenital or genetic disorder [3]. In the Dutch
Health Council report on genetic screening, the major
aim is defined as: "To enable people to decide upon a
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course of action that is acceptable for them" [3]. ANS in-
cludes:
1. Screening for sporadic conditions affecting the fetus
(infections, chromosomal disorders, malformations, ma-
ternal diabetes);
2. Family history for genetic risks;
3. Population screening for carriers of common reces-
sively inherited diseases.
Different health authorities in different countries have
pointed out various aspects of ANS. While the Danish
Health Council considers screening as a community-
based form of help based on the obligation to help the
weak, the Nuffield Council on Bioethics (in Britain)
points out that, although the primary aim seems to be to
improve the health of persons suffering from genetic dis-
orders, the benefits should include enabling individuals
to take account of the information for their own lives,
and empowering them as prospective parents to make
informed choices about having children [3].
Although the screening test is not usually in itself diag-
nostic, it detects a subgroup of those tested who are at
higher risk of having the disease or disorder than the
original population screened, in many cases it is possible
to make diagnoses with considerable accuracy.
Three different types of ANS methods are widely used;
1. Biochemical Screening In this technique, a single
specimen of blood taken from a pregnant women at
about 16-18 weeks of pregnancy, can be used to screen
for Down's Syndrome and open neural-tube defects. This
can detect about 60% of pregnancies with Down's Syn-
drome, about 90% of pregnancies with open spina bifida,
and virtually all cases of anencephaly [4]. Biochemical
screening tests are used to identify those women who are
at high enough risk to justify the hazards and costs of the
diagnostic procedures.
2. Genetic Screening The sensitivity and the specifici-
ty of genetic screening is fairly high. The test is carried
out either by amniosentesis or by Chorionic Villus Sam-
pling (CVS) at 14-16 weeks and 8-9 weeks respectively.
Using standard cytogenetic techniques it is possible to
culture amniotic fluid cells from as little as 10 ml. of am-
niotic fluid at 12 weeks, although successful culture be-
fore this time is currently less reliable. In CVS chorionic
tissue obtained via endoscopic biopsy is used to make the
types of fetal diagnoses by culture of amniotic fluid cells
The objectives of genetic screening developed by the
Royal College of Physicians (London) are:
- to allow the widest possible range of informed choice to
women and couples at risk of having children with an ab-
normality.
- to allow couples to embark on having a family knowing
that they may avoid the birth of seriously affected chil-
dren through selective abortion.
- to ensure optimal treatment of affected infants through
early diagnosis [4].
3. Ultrasound Screening The objectives of ultrasound
screening are defined as:
-to reduce the prenatal mortality and morbidity; and
-to allow the identification of a group of babies for whom
treatment in utero may be appropriate by defining struc-
tural abnormalities.
Antenatal Diagnosis
AND has four main purposes;
1) to inform and prepare parents for the birth of an af-
fected infant;
2) to allow in utero treatment, or delivery at a specialist
centre for immediate postnatal treatment;
3) to allow termination of an affected fetus;
4) to provide information so that parents may choose be-
tween 1, 2 and 3.
Evidently, the goal of AND is to help couples make an in-
formed choice, one which they feel is best for themselves
and their families. AND tests can be divided into those
involving measurements of chemicals in maternal blood,
imaging the fetus, and invasive tests to remove tissue of
fetal origin. The tests in the last group may be carried out
before 14 weeks' gestational age but after implantation,
beyond 14 weeks' gestational age, or in the pre-implanta-
tion period. The tests, which are carried out in the preim-
plantation period are embryo biopsy and polar body
analysis. The tests in the second group are fetal blood
sampling, fetal tissue biopsy, amniocentesis, and
transabdominal chorion biopsy. The tests in the first
group, that are the most widely used at present, are early
amniocentesis, transabdominal chorion villus biopsy or
sampling (CVS) and transcervical CVS. Table 1 [5] indi-
cated some of these antenatal tests with their time of ap-
plication, and detectable conditions.BMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
Preimplantation Diagnosis (PID)
Among other ANTs PID has a special feature. It aims to
avoid the possibility of an affected pregnancy complete-
ly. It is based on the simple strategy of sampling genetic
material from eggs or embryos within the first week of
their development following fertilisation. The genetic
material is used to detect whether a particular genetic
defect is present and whether the embryo will be affected
Table 1: Antenatal Tests
Type of test Detectable conditions Stage of
pregnancy
Invasive: mother only
MSAFP
Estimation of maternal serum Neural tube defects; Down's 16th-18th week.
alphafetoprotein in maternal syndrome.
blood.
Combined maternal blood
test
Estimation of MSAFP, chorionic Down's syndrome. 16th-18th week.
gonadotropin and/or
unconjugated oestriol.
Invasive: both fetus and
mother
Amniocentesis
A test involving the insertion, Chromosomal disorders; a 12th-14th week.
through the mother's abdomen, number of hereditary disorders
of a fine needle into the caused by a single gene; neural
amniotic sac and the removal of tube disorders.
amniotic fluid.
Chorion biopsy
A test involving the introduction Chromosomal disorders; a 8th-12th week.
through the mother's vagina or number of hereditary disorders
abdomen of a needle into the caused by a single gene.
womb and the removal of tissue
surrounding the fetus.
Fetoscopy
A test involving the introduction Chromosomal disorders; 16th-18th week.
through the mother's abdomen disorders detectable by fetal
of an instrument enabling the blood sampling; malformations.
examiner to see the fetus.
Cordocentesis
A test involving the insertion of Chromosomal disorders; 15th week
a needle through the mother's disorders detectable by fetal onwards.
abdomen (where the umbilical blood sampling.
cord of the fetus is attached to
the placenta) and then the
removal of fetal blood.
Non-invasive
Ultrasound scan
An instrument is passed over Fetal growth and development; Any time but often
the mother's bare abdomen multiple pregnancy; about the 16th
and a picture of the fetus is malformations, including neural week to check
produced on a screen. tube defects. dates and
development.
Radiography
The mother's abdomen is X- Skeletal abnormalities requiring 20th week
rayed. This is hardly ever done a picture of the whole skeleton. onwards.
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by it. This procedure theoretically enables the selection
of only healthy embryos for implantation, or the genetic
modification of embryos with disabilities or genetic de-
fect prior to implantation. Beside other advantages PID
is more abstract and less invasive than other AND tech-
nologies. PID is done at an earlier time than AND-up to
five days as against ten-sixteen weeks. This may lessen
feelings of emotional attachment in that PID can prevent
termination of a pregnancy diagnosed as affected at later
stages of gestation. It is argued that the earlier the diag-
nosis of genetic conditions, the easier the moral choices
for many women or couples. For those who hold that the
early fetus (i.e. 'pre-sentient' or not yet a 'person') is mor-
ally different from the older fetus, early identification of
fetal genetic conditions will diminish the moral confu-
sion of abortion [6]. R. G. Edwards, the pioneer of in vit-
ro embryology, observed that: "Identifying embryos with
genetic abnormalities would offer an alternative to amni-
ocentesis during the second trimester of pregnancy, and
the 'abortion in vitro', of a defective preimplantation em-
bryo would be infinitely preferable to abortion in vivo at
twenty weeks of pregnancy or thereabouts as the result of
amniocentesis are obtained" [7].
Although it seems emotionally (perhaps also ethically)
less problematic, there are still objections to the manip-
ulation of human preimplantation embryos [8]. The ob-
jections are generally based on the view that there is, in
principle, no difference between an eight-cell embryo,
and a fetus or a child. In this view, they are all human in-
dividuals and, since informed consent is not possible,
they should not be interfered with. On this basis, termi-
nating an affected pregnancy halfway through the preg-
nancy is no more or less acceptable than discarding
affected preimplantation embryos. The opposing view
draws a sharp distinction between these stages of a hu-
man being's development and consequently argues that
the ethical constraints are different at each stage. In this
case, manipulation of early embryos to remove cells for
genetic analysis is acceptable and some would argue that
discarding affected embryos is preferable to doing so at
later stages. Another concern about PID is that, after pre-
natal diagnosis, there is at least a theoretical possibility
that a couple will decide to carry a genetically abnormal
fetus to full-term. In the context of preimplantation diag-
nosis and IVF, the decision-making process is eliminat-
ed; the genetically abnormal embryo will not be
implanted [9].
Benefits of antenatal testing
There can be a little doubt, on the face of it, that the tech-
niques just described were devised to help people, and
aim to enable parents to plan their future family knowl-
edgeably. However, many authorities from various fields
have expressed some serious concerns about them. It is
important to define the 'real' aims of these techniques,
and see how they work in practice. It is thought that these
techniques may not necessarily have been developed
with the interests of women primarily in mind, nor are
necessarily applied to further women's interests [10]. A
governmental document from DHSS (in United King-
dom) may help us to clarify our thinking about the 'real'
aim of these technologies. It reads: "...because caring for
the handicapped can impose great burdens on our socie-
ty the prevention of handicaps...in addition to its other
benefits may save money. The costs of providing amnio-
centesis for all expectant mothers over the age of 40
years, and maternal serum AFP screening for all preg-
nant women, would be more than offset by the economic
benefits in terms of savings of expenditure on children
and adults with Down's Syndrome and spina bifida" [11].
Rational as this sounds, this kind of rational-economic
thinking may degrade society's willingness to accept and
care for abnormal children, while at the same time en-
larging the category of unacceptable abnormality and
narrowing the range of acceptable normality. If Down's
syndrome and spina bifida are 'too' expensive today,
what will become 'too' expensive if the economic climate
becomes gloomy [12]?
Whether and how far it is right to accommodate cost-
benefit analysis in the medical field has always been
problematical. As has the question of whether economi-
cal considerations should affect clinical decisions [13].
Some reports have compared, for populations with vary-
ing incidence of neural tube defects, the benefits of a an-
tenatal screening programme (in terms of number of
births with neural tube defects prevented) against the
physical costs (in terms of the number of normal fetuses
harmed by amniocentesis) the cost-benefit ratio be-
comes progressively less favourable as the population in-
cidence of neural tube defects decreases. This, together
with the fact that around 85 per cent of babies with neu-
ral tube defects are either still-born or die within the first
year of life, means that, in regions with a low incidence of
neural tube defects, it is possible that more unaffected
pregnancies may be harmed than handicapped children
avoided [14]. Another recent report has also indicated
the 'possible cost' of antenatal diagnosis. With its annual
report, the Danish Council of Ethics has published a de-
bate outline on ethical issues in fetal diagnostics. It con-
sists of a report on the past, present and future of fetal
diagnostics, commissioned from a Danish science writer,
and a discussion of the Council's deliberations on the is-
sue. The report reads "Just under 120,000 fetuses exam-
ined. Over 2,200 sick or deviant fetuses identified and
aborted. Loss of some 1,100 presumably healthy fetuses
as a side-effect of the examination used" [15]. The coun-
cil sums up that "it is essential to stress that, irrespectiveBMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
of the stance taken on fetal diagnostics, it will be prob-
lematic for either one or the other party involved in fetal
diagnostics". Table 2 [5] outlines the costs and benefits
of AND typically noted by medical practitioners involved
in AND. The table makes it clear that medical practition-
ers usually focus on the pregnant woman rather than on
the fetus when they assess the advantages and disadvan-
tages of antenatal diagnosis.
As the table shows, it is possible to argue that AND tests
can benefit everyone but the prenate. However, there is
no denying that AND can be a vital aid in monitoring
pregnancies for therapeutic reasons with a view to safe
deliveries, and most AND is performed in order to pre-
vent the birth (or conception) of disabled children. This
motivation is clearly expressed in the report of the Royal
College of Physicians: "Unless prenatal diagnosis is to be
devoid of practical application when it reveals a major
defect in the fetus, a responsible doctor must discuss
with the parents the option of terminating that pregnan-
cy and must in some circumstances provide information
that may deter them from further reproduction" [16].
The termination of pregnancy and its acceptability is tak-
en elsewhere [17], but it is worth mentioning here that it
is highly questionable to claim termination of pregnancy
as in the 'child's best interest'.
It has been argued that the availability of antenatal
screening and diagnostic testing has changed the experi-
ence of pregnancy. Before the development of antenatal
testing for fetal abnormality, the fetus was assumed to be
healthy, unless there was evidence to the contrary. The
presence of antenatal testing and monitoring shifts the
balance towards having to prove the health or normality
of a fetus [18]. Pregnancy has come under medical con-
trol to such a degree that it is almost treated as a disease,
and pregnant women have accepted their role as patients
in need of medical help. Both the medical profession and
pregnant women now regard antenatal diagnosis as a
necessary part of prenatal care.
Table 2: Costs and benefits of antenatal diagnosis typically noted by the medical profession
Costs Benefits
For hospital and health authorities
1) Costs in connection with diagnosis, 1) Scarce resources allocated to children with good prognosis (rather than to severely handi-
capped children).
2) Costs involved in performing termination.
3) Costs in connection with counseling services.
For pregnant women and fathers-to-be
Availability of prenatal diagnosis
1) Increase in the number of healthy children born to parents at risk who, had prenatal diagnosis 
not been available, would have avoided becoming pregnant.
Diagnostic procedures
1) Risk of fetal loss or injury,
2) Maternal hazards,
3) Maternal anxiety.
Result:
true negative
2) Reassurance,
3) An increase in the number of healthy children born to parents at risk who, had the test result 
not been negative, would have terminated pregnancy on grounds of risk.
false negative
4) False reassurance.
false positive
5) Abortion of healthy fetus,
6) Grief and adverse psychological consequences 
of termination of non-affected pregnancy.
true positive
-followed by abortion-
7) Grief and adverse psychological consequences 
of termination of affected pregnancy.
4) Averted parental distress and burden of care for disabled child,
5) Additional non-disabled children.
-not followed by abortion-
6) Time to prepare for the birth of the disabled child.BMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
Barbara Rothman, in her book The Tentative Pregnan-
cy, maintains that it is the medical profession that has
created a need for antenatal diagnosis for 'reassurance'
by creating what she calls 'genetic anxiety', thereby capi-
talising on women's normal fear of having a 'defective',
socially unacceptable, child, just as deodorant and
mouthwash companies first had to create anxiety about
socially unacceptable body odour before they could mar-
ket their product [19]. However, if there really is a nor-
mal fear of having a 'defective', socially unacceptable
child, then it is the duty of health care professionals to
find a solution. Rothman's critique may well be a re-
sponse to a certain paternalism in the attitudes of the
medical vis-à-vis ANT. As in many other medical inter-
ventions, informed consent and intelligent counselling
are of prime importance in ANT procedure.
Effect of counselling
Counselling before and after ANT is crucial [20]. It is
suggested that, in an ideal counselling, the parents
should be told that there is no 'right' decision to be made,
and it should be made clear that whatever their decision
is, it will be supported. They must also be clear about
whether it is a screening test or a diagnostic test, and how
accurate it is in their particular situation. They need to be
aware of the risks involved to the pregnancy and the pos-
sible consequences of dealing with the information the
test provides [21]. Normally, medical professionals
should not offer antenatal diagnosis, because it is known
that it is very difficult for a woman to decline AND when
offered [22]. Instead, they should discuss the feasibility,
accuracy and clear-cut details of any such tests, including
the dangers of it.
Three pieces of information which women tend to cite as
reasons for changing their minds about tests are;
- the level of risk they have for the condition in question;
- the miscarriage risk of the test being considered;
- the method of termination which would be offered if
they chose to terminate the pregnancy following an ab-
normal result from the test in question [21].
To provide this kind of ideal counselling, firstly there
must be enough well-trained health care professionals.
The units that provide these services must also provide
suitable training opportunities and satisfy the expecta-
tions of users of ANT services.
Chadwick suggests that 'genetic counselling' includes the
following kinds of activity:
a) advising adults, pre-conception, of the probability of
their conceiving a child with a genetic disorder;
b) advising adults, post-conception, and as a result of
some method of fetal screening, as to whether or not the
fetus is suffering from a genetic disorder;
c) alerting them to the options open to them [23].
Clearly, it is important to leave the final decision to the
parents. Doctors are supposed to not impose their own
moral attitudes upon their patients. If they find them-
selves disagreeing with the moral stance of their patients
over these issues they should explain their situation and
advise the patients to consult a clinical geneticist [24].
However, it seems it does not work like this in practice.
Because, making rules does not mean everything. The
most important and difficult thing is applying them. And
this depends on the development of public awareness
and education [25]. It is argued that the conflict of inter-
ests between providers and users of antenatal screening
services is clearly reflected in the counselling process. At
all stages of screening, counselling is systematically bi-
ased towards encouraging women to take up the tests
and have an abortion if an abnormality is detected, rath-
er than providing women with the information and sup-
port they require to make an informed choice and to
avoid unnecessary distress [10]. The Medical Research
Council (MRC) stated in its report that: "Of the 112 wom-
en (including high risk women) interviewed after they
had had an amniocentesis, 28 (24 per cent) were una-
ware that amniocentesis carried a risk of miscarriage,
and 96 (86 per cent) were unaware of any other possible
hazards. Of the 16 women aware of the possible risks to
the newborn infant, 12 had obtained this information
from sources other than the medical staff who had coun-
selled them about amniocentesis" [14]. There is litera-
ture available which is compatible with the MRC's
report. For example: "Women undergoing routine ante-
natal screening are generally under-informed about the
tests they are being offered and may subsequently under-
go. For example, 39 per cent of women who had recently
undergone maternal serum alphaprotein (MS-AFP)
screening for open neural tube defects were unaware
that they had even had the test" [26].
Self-evidently, this is not an ideal situation for any health
care service. Apart from the failure to provide enough in-
formation, the bias toward termination of pregnancy in
the event of abnormality detection is another controver-
sy in AND procedure. It is generally conceded by the
medical profession that the primary aim of antenatal di-
agnosis is the detection, and subsequent abortion, of ab-
normal fetuses. Because of the procedural risks to theBMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
fetus and the lack of effective methods of fetal therapy for
most malformations, antenatal diagnosis is a rational ac-
tivity only if abortion is seen as an acceptable alternative
[27]. However, this kind of approach to prenatal diagno-
sis may be considered not only unfair, but also rather un-
ethical, by some people.
In order to describe the feelings of parents who are
pushed to have a termination, one needs to have experi-
enced it. But it is not too hard to comprehend the diffi-
culty for parents who decide not to terminate a
pregnancy with a diagnosed fetal abnormality-they must
face, as well as the distress of coping with a handicapped
child, the mental and emotional struggle of defending
their decision before health professionals [28]. In an ide-
al ANT procedure, health care professionals are expected
to strengthen their role as providers of support to the
families for whom they care. They should provide moral
support and practical help both to those who terminate
fetuses at risk of malformation or disease and to those
who choose not to do so. Furthermore, ANT providers in
this field are expected to prevent any possibility that fi-
nancial considerations might affect clinical behaviour.
Angus Clarke, a clinical geneticist, makes a distinction
between giving advice-a prescriptive activity, often sub-
tly authoritarian when applied to the field of personal re-
productive decisions-and the informing, supportive, and
'enabling' process of counselling [29]. And he adds: "We
do not tell people what to do but support them in reach-
ing decisions, with the consequences of which they then
have to live for the rest of their lives. We may have to in-
form clients about the disadvantages of their preferred
course of action so that they can examine all options
(such as a permanently handicapped child, or permanent
remorse at a termination), but, when the decision is gen-
uinely their own, the parents are much more likely to be
able to live with it" [29].
Another counselling issue related to ANT is that of direc-
tiveness. It has been argued that pre-test counselling
should be non-directive since it is counsellee and not the
counsellor whose entire future life may be affected by de-
cisions made at the sessions. However, those present at
the Third European Meeting on Psycho-social Aspects of
Genetics (1992) voted by a narrow majority that non-di-
rective genetic counselling was not achievable in prac-
tice. This is partly due to the fact that counsellors come
to sessions with their own views about what they think
they would do in the situation or what they think a re-
sponsible person should do. These views may be held
consciously or unconsciously but they will influence the
counsellors' choice of words in describing conditions,
tests and probabilities, their facial expression, body lan-
guage, and the order in which things are explained and
the amount of time spent on different topics. For this
reason non-directive counselling is thought to be an un-
attainable ideal. It is not because of a personal failure on
the part of the genetic counsellor but as a direct result of
the structure of the encounter between counsellor and
client [30]. Clarke argues that the counsellor's conscious
or even unconscious motives are irrelevant; the offer and
acceptance of genetic counselling has already set up a
likely chain of events in everyone's mind [30].
From all these discussions it becomes apparent that non-
directive counselling is a myth. Today, counselling is di-
rective, and its direction is towards having ANT and go-
ing to termination if something is wrong with the 'baby in
the womb'. Let us now discuss (in terms of its benefits to
different parties) the consequences of ANT.
Consequences of antenatal testing
The primary purpose of AND is to relieve parents of anx-
iety over inheriting a genetic disease, or giving birth to a
child with congenital abnormalities (e.g. for older wom-
en), and this is the major outcome. AND is defined as in-
tended to inform parents of the birth of an affected
infant, to allow in utero treatment, or delivery at a special
centre for immediate postnatal treatment, or to allow
termination of an affected fetus; in practice the last of
these three has become the most used course of action.
Many writers have criticised this attitude as wrong.
Among the argument put forward is that wide accept-
ance of selective abortion diminishes the importance of
and the motivation for, research on cures for genetic dis-
orders, whether in utero or after birth to be taken up.
There is a little doubt that relatively non-invasive tech-
nology whose primary purpose is to diagnosis treatable
disorders and cure them before or after birth would be
warmly welcomed by parents and ethicist alike. Howev-
er, the present reality is that antenatal diagnosis rarely
leads to fetal therapy. In fact, in many cases normal fe-
tuses are negatively effected from the CVS procedure
[31]. There is also evidence that the availability of AND
may be leading scientists to leave research on cures of ge-
netic disorders in favour of selective abortion. During the
1960s there were two to three times as many people
working on a cure for Tay-Sachs disease than at present.
The emphasis now is put on an antenatal diagnosis for
Tay-Sachs disease, followed by abortion in the case of a
test positive. Similarly, as soon as an antenatal diagnos-
tic test for Huntington disease became available in the
early 1980s, 'funds began to disappear for research to
find a cure' [31]. Beside these trends, the greater social
acceptability of abortion, and increased pressure on
women to undergo AND from health insurance compa-
nies medical professionals and government agencies, are
all possible negative consequences of AND. Alongside
the benefits of diagnosing abnormalities in early stagesBMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
of pregnancy, there are some potential psychological
costs. These include anxiety, loss of confidence about the
pregnancy and negative attitudes towards the baby. A
major worry is, or ought to be, that the availability of
AND may make people increasingly intolerant of the dis-
abled and hostile towards parents who choose not to
abort affected fetuses [5].
The use of AND for sex selection and termination of
pregnancy if the fetus is of the undesired sex is, rightly,
described as an atrociously unethical practice [32]. How-
ever, it is also easy enough to see the wish to have a boy
or a girl as simply satisfying the desires or needs of the
future parent(s) or other relatives. Strictly argued, sex
preference could be regarded in the same way as exercis-
ing a preference for a normal, healthy child, rather than
an unhealthy one. If someone has the right to do some-
thing to have (or not to have) a disabled child, he or she
could argue the same right to have (or not to have) a child
of particular sex. Strictly speaking, both properties, be-
ing healthy/disabled or male/female are morally, neu-
tral. The reasoning follows: if it is right to terminate the
pregnancy in case of disability, is it not equally right to
terminate it in case of undesired sex, or vice versa. Ma-
honey observed that parents are necessarily determining
a child's genetic constitution, its environment, its char-
acter and its entire future by the unavoidable choices
they make, whether consciously or not: the choice to
have a child, the choice to do so in a particular country or
town or climate, the choice to send it to a particular
school, the choice to encourage it or discourage it in cer-
tain forms of behaviour, and so on. He went on to con-
clude: "I do not see why, within such a chain of choices,
the choice of sex should be singled out for particular
moral disapproval" [33]. It is wrong, it could be argued,
to differentiate undergoing an AND with the intention of
finding out the health condition of the fetus with termi-
nation as a possibility, from undergoing an AND to check
the sex of the fetus with, again, termination as a possibil-
ity. In principle, both can be seen as equally morally ac-
ceptable or unacceptable.
In 1883 Francis Galton started using the word 'eugenics'
defining as the science of improving stock -not only by
judicious mating, but whatever tends to give the more
suitable races or strains of blood a better chance of pre-
vailing over the less suitable than they otherwise would
have had [34]. However, later the social policy interven-
tion, along with genetics measures exists in many coun-
tries [34]. These policies do not aim to coerce or
mandatory who will be conceived and born, they empha-
sise the elimination of hereditary disease and handicaps
through antenatal testing. This eugenics thinking is jus-
tified by some, since it is not a science based on Nazism,
racism, discrimination to minorities and genetic deter-
minism. It is a science which inherent in the core eugenic
doctrine of improving the stock of humankind by appli-
cation of the science of human heredity. This science can
be called 'negative eugenics'.
Despite all improvements, still ANT is not 100 per cent
accurate. It is reported that: "Routine screening tests do
not detect all cases. MS-AFP detects about 80 percent of
cases of spina bifida. Although smaller, there is a false
negative rate from both CVS and amniocentesis. Inher-
ent in all screening tests is the possibility of a false posi-
tive result" [26]. The routine use of ultrasound may
result in the detection of symptomless minor anomalies,
the incidence and natural history of which are unknown.
Although these are not indications for a termination,
their detection means that women face the rest of their
pregnancies with the knowledge that their child has an
abnormality where implications are unknown. This may
have two different consequences: the diagnosis of a pos-
sible abnormality may affect the acceptance of the baby
by the parents and create negative attitudes in them to-
wards it; or it may alert parents to prepare emotionally
and psychologically for their (possibly) handicapped ba-
by. In either case parents have 5-6 months to make up
their minds-which is better than being surprised in the
labour room.
For all couples with an abnormal result, there may be
moral or religious objections or social pressures about
termination, there may be disagreements between the
couple as to the correct course of action and it is not al-
ways possible to give the couple a clear idea of the partic-
ular disability of that particular fetus. There is also the
extremely important emotional consequence of the deci-
sion-the feeling of responsibility for the loss of a wanted
child, which many couples describe as guilt. Clearly, in
these situations, the decision making is more difficult,
and for those couples who choose to terminate a preg-
nancy at less than 100 per cent risk of the fetus being af-
fected, there will be lingering doubts about whether the
baby might, after all, have been normal. A study has
shown that in 38 per cent of the cases there are differenc-
es between the attitudes of parents towards AND [22].
While discussing the harms and the benefits of the ante-
natal screening programmes Atkins and Hey suggested
that: "It is possible that some screening programmes
currently do more harm than good. Antenatal diagnosis
does not always increase a child's chance of survival.
Liveborn children with an uncomplicated abdominal
wall defect, for example, have an excellent chance of sur-
vival and a negligible risk of long-term disability, but an-
tenatal diagnosis can bring with it ill-justified pressure
for the pregnancy to be terminated" [1].BMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
In Whose Interest?
There can be no objection if the aim of ANT procedure is
to diagnose abnormality and cure it, if that is possible.
However, many people are uneasy about terminating the
life of the fetus. At this stage the question arises: "Whose
interest does ANT serve-the interest of the child-to-be, or
of the parents, or of the siblings' and/or of the society as
a whole?" In the event of an abnormality being diag-
nosed, treatment before birth, or birth in a centre where
the necessary interventions are possible, the child-to-be
would definitely benefit from ANT. In this case everyone
will have tried their best to give the unborn a (better) life.
There is a question whether having a child with an ab-
normality is good for parents, siblings, or the society. In
fact the interest of the child/person vis-à-vis having a life
at all, overweighs others' comparatively trivial interests,
for almost any interest is trivial compared to life. Of
course, it is not convenient to have a disabled child/sib-
ling/citizen; of course, everyone would prefer to have a
healthy one. However, in AND and subsequent termina-
tion, the choice is not between being born with health or
being born without it; rather, the choice is between a
worldly existence or none at all. And the difference be-
tween existence and non-existence is beyond compari-
son [35].
Should we then admit that, except where pre- or post-na-
tal treatment is the aim, AND has nothing to do with the
prenate's interest, but with parents', siblings' and/or so-
ciety interest? Several authors have said that much ante-
natal diagnosis is for the benefit of the parents rather
than the fetus [36]. But is it that straightforward?
Does the birth of a disabled child not add to the suffering
in the world? Harris has argued on one occasion that:
"We have an obligation to prevent suffering and disabil-
ity, or, more abstractly that we should try to produce a
world with less rather than more suffering in it, that we
should try to produce a happier world. So indeed there is
clearly a moral obligation to provide such screening
where possible so that parents can have the opportunity
to choose not to bring suffering or disability into the
world" [37]. A counterargument was put by Galjaard, a
professor of cell biology: "Parents who have integrated
their suffering, having had one or more handicapped
children now stand up and defend the birth and the ex-
perience of these handicapped children as having made
them happier, their marriage better, and so on" [37]. To
this Harris replied with an analogy: "Imagine a pregnant
woman has a condition. The fetus is damaged, but there
is a simple risk-free procedure which will remove the
damage. She just has to imbibe orange juice and the
handicap will be removed. But she says no, she does not
want to do it, she does not want this therapy because the
last handicapped child she had made her so happy she
intends to have another. What one would feel about such
a decision gives the key to the respectability of the happi-
ness argument from other people's misery" [37]. As I
have argued elsewhere in discussing this analogy, if all
that is needed is 'to imbibe orange juice and remove the
handicap', then drinking orange juice is the only course
of action that any sensible person would take [38]. But in
reality there is rather more involved, and rather more at
stake, than a simple drink of orange. The ANT procedure
is not risk free (as we saw, above). Thereafter, the choice
is not 'drink orange juice and have a healthy baby', which
the mother perversely refuses because she 'prefers' to
have a disabled child. Rather, the choice is (after the risk
of ANT): have a child who may have disability or not have
the child, i.e. terminate your pregnancy.
Furthermore, some genetic disorders are diagnosed an-
tenatally which may not surface for many years after
birth, and possibly only after the parents themselves are
deceased. Huntington's chorea would be a case in point.
In this circumstance, should termination follow ANT, al-
though there is 20 or 30 years of happy, normal life ex-
pectancy? Harris answered the question in this way: "I
think it would be better not to bring that degree of suffer-
ing, albeit postponed, into the world. Taking a decision
when no person is in being is quite different from saying
to a 20 year-old who has Huntingdon's and who will die
from it that their life has not been worth having. When it
is an embryo or a fetus, before it has a conscious life, the
calculation to be made is which action causes the least
suffering, and I think termination is the answer to that
question" [37]. First of all we must admit that the com-
parison to be made is not that between nonexistence and
a deprived life but that between a defective life and the
life of a normal child. Of course it would be better not to
bring that degree of suffering into the world. And, it is
absolutely preferable to take a decision when there is as
yet, 'no person in being'. However as soon as an individ-
ual life is being, there is no point in comparing that life,
however deprived it may be, with non-existence. This
does not mean rejecting outright the possibility that
there are some situations in which it is better to be dead.
But that is a decision for the individual concerned, not a
decision for others to take, whoever they are.
In sum, there are two questions before us: 1) determine
the 'morally safe' period to manipulate the prenate, and
2) to improve AND techniques to in order to detect ab-
normalities within the 'safe' period. As was argued else-
where, the 'morally safe' period could be up to the eighth
week after conception [39], unless the zygote's normal
development has been prevented by some measure such
as freezing. During this period it is morally less problem-
atic to check the prenate's state of health because, should
we decide not to carry on the prenate's life, we would notBMC Medical Ethics (2001) 2:3 http://www.biomedcentral.com/1472-6939/2/3
be intervening in and terminating an individual human
life, a distinct person. Now the only AND technique cur-
rently available to enable us to test the prenate's state of
health during the 'safe' period is preimplantation diag-
nosis (PID). It is carried out in the first week of gestation
and before implantation; it does not pose any medical or
moral problem. PID therefore the most reliable and mor-
ally acceptable of the current ANT techniques [12].
Conclusion
In conclusion we can say that, although there are differ-
ent views in the wide bioethics community, antenatal
screening and antenatal diagnosis are new technologies
developed to contribute to our happiness and welfare,
but like many other new technologies, they are accompa-
nied by new moral controversies. It is not proper to con-
clude that "ANT is good", or "ANT is evil"; deciding this
issue is firmly attached to a number of ethical dilemmas
at the heart of which is the 'moral status of the prenate'.
So, deciding the issue is dependent upon the views of the
person, and a case-by-case approach can be suggested. If
any embryological stage is defined as the beginning of a
human individual, only testing but not termination may
be allowed. We have stressed the vital importance of pro-
viding the parents with good counselling before and after
ANTs. The aim of good counselling is to inform and ena-
ble parental understanding and choices with respect to
their unborn child; health care professionals should not
impose their own beliefs upon the parents [40]. What
they can and must do is to debate the issues among
themselves, to review their criteria for advising ANT pro-
cedures, and for the choices that may follow, so that they
are providing the best possible service to their patients
who are, of course, 'persons', a category which the pre-
nates may also belong, at least in the minds and hearts of
their parents.
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